LoginSignup
Cryo-Cell Intl logo

Cryo-Cell Intl

Stock
Stock
Ticker: CCEL
CCEL

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 

$0.433

CHART BY

Frequently asked questions

What is Cryo-Cell Intl's market capitalization?

The market capitalization of Cryo-Cell Intl is $25.13M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Cryo-Cell Intl?

Cryo-Cell Intl's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.303. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Cryo-Cell Intl's stock?

Currently, 1 analysts cover Cryo-Cell Intl's stock, with a consensus target price of $8.50. Analyst ratings provide insights into the stock's expected performance.

What is Cryo-Cell Intl's revenue over the trailing twelve months?

Over the trailing twelve months, Cryo-Cell Intl reported a revenue of $31.57M.

What is the EBITDA for Cryo-Cell Intl?

Cryo-Cell Intl's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.85M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Cryo-Cell Intl?

Cryo-Cell Intl has a free cash flow of $5.25M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Cryo-Cell Intl have, and what sector and industry does it belong to?

Cryo-Cell Intl employs approximately 76 people. It operates in the Health Care sector, specifically within the Other Transportation industry.

What is the free float of Cryo-Cell Intl's shares?

The free float of Cryo-Cell Intl is 3.79M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$25.13M
EPS (TTM) 
-$0.303
Free Float 
3.79M
Revenue (TTM) 
$31.57M
EBITDA (TTM) 
$1.85M
Free Cashflow (TTM) 
$5.25M

Pricing

1D span
$3.117$3.248
52W span
$2.87$6.59

Analyst Ratings

The price target is $8.50 and the stock is covered by 1 analysts.

Buy

0

Hold

1

Sell

0

Information

Cryo-Cell International, Inc. is a cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Umbilical Cord Blood and Cord Tissue Stem Cell Service, PrepaCyte CB, and Public Cord Blood Banking. The Umbilical Cord Blood and Cord Tissue Stem Cell Service segment refers to cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use. The PrepaCyte CB segment focuses on the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells. The Public Cord Blood Banking segment relates to the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company was founded in 1989 and is headquartered in Oldsmar, FL.

Employees
76
Industries
Other Transportation
Sector
Health Care

Identifier

Primary Ticker
CCEL

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin